- 5 years ago
Roche's Actemra (tocilizumab) is in severe shortage globally (istock.com/Teka77)
29 September 2021 The TGA has given Roche a provisional determination for its rheumatoid arthritis…
This is subscriber-only content. Please login to continue reading.
